Fmoc-alpha-Me-D-Pro-OH

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.
Fmoc-alpha-Me-D-Pro-OH(CAS 1286768-33-9)

CAT No: CP25631

CAS No:1286768-33-9

Synonyms/Alias:1286768-33-9;1-Fmoc-2-methyl-D-proline;N-alpha-(9-Fluorenylmethyloxycarbonyl)-alpha-Methyl-D-proline;(R)-1-(((9H-FLUOREN-9-YL)METHOXY)CARBONYL)-2-METHYLPYRROLIDINE-2-CARBOXYLIC ACID;(2R)-1-(9H-fluoren-9-ylmethoxycarbonyl)-2-methylpyrrolidine-2-carboxylic acid;(2R)-1-{[(9H-fluoren-9-yl)methoxy]carbonyl}-2-methylpyrrolidine-2-carboxylic acid;(2R)-1-[(9H-fluoren-9-ylmethoxy)carbonyl]-2-methylpyrrolidine-2-carboxylic acid;Fmoc-D-(Me)Pro-OH;(2R)-1-(((9H-fluoren-9-yl)methoxy)carbonyl)-2-methylpyrrolidine-2-carboxylic acid;MFCD03095628;Fmoc-beta-Me-D-Pro-OH;Fmoc-|A-Me-D-Pro-OH;SCHEMBL18154894;AKOS028114671;AB93480;AS-82417;DB-420244;CS-0439216;E83304;EN300-740853;(2R)-1-(9H-fluoren-9-ylmethoxycarbonyl)-2-methyl-pyrrolidine-2-ca rboxylic acid;853-519-7;

Chemical Name:N-alpha-(9-Fluorenylmethyloxycarbonyl)-alpha-Methyl-D-proline

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
M.F/Formula
C21H21NO4
M.W/Mr.
351.4
Sequence
Three Letter Code:Fmoc-D-aMePro-OH
Application
Nucleotides synthesis; drug screening
Size
1 g;5 g;
InChI
InChI=1S/C21H21NO4/c1-21(19(23)24)11-6-12-22(21)20(25)26-13-18-16-9-4-2-7-14(16)15-8-3-5-10-17(15)18/h2-5,7-10,18H,6,11-13H2,1H3,(H,23,24)/t21-/m1/s1
InChI Key
VOQFOIAFEGUNRZ-OAQYLSRUSA-N

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
Custom Conjugation ServiceEpitope Mapping ServicesPeptide Analysis ServicesPeptide Modification ServicescGMP Peptide ServicePeptide Nucleic Acids SynthesisPeptide CDMOPeptide Synthesis Services
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers